Results for tag: "Merkel Cell Carcinoma Drug"

Merkel Cell Carcinoma (MCC) is a rare and aggressive form of skin cancer. It is caused by a virus, and is most commonly found in people over the age of 50. Treatment for MCC typically involves surgery, radiation, and chemotherapy. In recent years, targeted therapies and immunotherapies have been developed to treat MCC. These drugs target specific molecules in the cancer cells, and can be used in combination with other treatments. The Merkel Cell Carcinoma Drug market is a rapidly growing segment of the Skin Cancer Drugs market. It is driven by the increasing prevalence of MCC, as well as the development of new treatments. The market is expected to continue to grow in the coming years, as more treatments become available. Some companies in the Merkel Cell Carcinoma Drug market include Merck, Bristol-Myers Squibb, Pfizer, Novartis, and Roche. Show Less Read more